妊娠期及产褥期脓毒症早期识别的研究进展

周东旭; 杨大燕; 王涛

doi:10.3877/cma.j.issn.2096-1537.2021.04.004

中华重症医学电子杂志 >

2021 , Vol. 07 >Issue 04: 304 - 308

DOI: https://doi.org/10.3877/cma.j.issn.2096-1537.2021.04.004

专题笔谈

妊娠期及产褥期脓毒症早期识别的研究进展

周东旭 ¹ ,
杨大燕 ¹ ,
王涛 ^,¹^,^†

展开

^1.550000　贵阳，贵黔国际总医院ICU

通信作者：王涛，Email：Wtlq20190109@163.com

Copy editor: 卫轲

收稿日期: 2021-09-26

网络出版日期: 2022-01-29

版权

未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计，除非特别声明，本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。本刊为电子期刊，以网刊形式出版。

收起

Progress in early recognition of sepsis during gestational period and puerperium

Dongxu Zhou ¹ ,
Dayan Yang ¹ ,
Tao Wang ^,¹^,^†

Expand

^1.Department of Critical Care Medicine, Guiqian International General Hospital, Guiyang 550000, China

Corresponding author: Wang Tao, Email: Wtlq20190109@163.com

Received date: 2021-09-26

Online published: 2022-01-29

Copyright

No content published by the journals of Chinese Medical Association may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journals without permission.

All articles published represent the opinions of the authors, and do not reflect the official policy of the Chinese Medical Association or the Editorial Board, unless this is clearly specified.

Fold

摘要

妊娠期及产褥期脓毒症是孕产妇死亡的重要原因。因该人群特殊生理，目前全世界对于妊娠期及产褥期脓毒症早期识别及诊断仍缺乏统一的标准，故对该类人群脓毒症的诊治相对滞后，这是导致其不良预后的原因之一。本文通过复习相关文献，对妊娠期及产褥期脓毒症的早期识别、危险因素及处理进行综述，以加强对妊娠期及产褥期脓毒症的早期识别。

关键词： 妊娠期; 产褥期; 孕产妇; 脓毒症; 产科感染

本文引用格式

周东旭 , 杨大燕 , 王涛 . 妊娠期及产褥期脓毒症早期识别的研究进展[J]. 中华重症医学电子杂志, 2021 , 07(04) : 304 -308 . DOI: 10.3877/cma.j.issn.2096-1537.2021.04.004

Abstract

Sepsis during gestational period and puerperium is an important cause of maternal death. Due to the special physiology of this population, there is still no uniform standard for the early recognition and diagnosis of sepsis during pregnancy and puerperium worldwide. Therefore, the diagnosis and treatment of sepsis in this population is relatively lagging, which is one of the reasons for its poor prognosis. This article reviews the relevant literature to review the early identification, risk factors and management of sepsis during gestational period and puerperium, so as to strengthen the early recognition of sepsis during gestational period and puerperium.

Key words： Gestational period; Puerperium; Maternal; Sepsis; Obstetrics infection

参考文献

原文顺序 | 文献年度倒序 | 文中引用次数倒序

1	Perner A, Cecconi M, Cronhjort M, et al. Expert statement for the management of hypovolemia in sepsis [J]. Intensive Care Med, 2018, 44(6): 791-798.

2	Prescott HC, Angus DC. Postsepsis morbidity [J]. JAMA, 2018, 319(1): 91.

3	Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority - a WHO resolution [J]. N Engl J Med, 2017, 377(5): 414-417.

4	Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003, 348(16): 1546-1554.

5	WHO. Shining a spotlight on maternal and neonatal sepsis: World Sepsis Day 2017 [Z/OL]. (2017-9-12)[2018-10-20].

6	Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis [J]. Lancet Glob Health, 2014, 2(6): e323-333.

7	Kumar A, Roberts D, Wood KE, et al . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock [J]. Crit Care Med, 2006, 34(6): 1589-1596.

8	Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.

9	Shankar-Hari M, Phillips GS, Levy ML, et al. Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 775-787.

10	Bonet M, Nogueira Pileggi V, Rijken MJ, et al. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation [J]. Reprod Health, 2017, 14(1): 67.

11	Bowyer L, Robinson HL, Barrett H, et al. SOMANZ guidelines for the investigation and management sepsis in pregnancy [J]. Aust N Z J Obstet Gynaecol, 2017, 57(5): 540-551.

12	Chebbo A,Tan S,Kassis C,et al. Maternal sepsis and septic shock [J]. Crit Care Clin, 2016, 32(1): 119-135.

13	樊尚荣. 产科重症感染的多学科防治 [J/CD]. 中华产科急救电子杂志, 2017, 6(3): 129-132.

14	张惜阴. 实用妇产科学 [M]. 北京: 人民卫生出版社, 2003: 467.

Acosta CD, Bhattacharya S, Tuffnell D, et al. Severe maternal sepsis: identifying actions to address morbidity and mortality. In Knight M,Acosta C,Brocklehurst P,et al eds. Beyond maternal death: improving the quality of maternal care through national studies of 'near-miss'maternal morbidity [J]. Programme Grants Appl Res, 2016, 4(9): 41-64.

16	刘平, 樊尚荣. 妊娠期和产褥期脓毒症 [J]. 中华产科急救电子杂志, 2013, 2(4): 253-256.

17	陈磊, 刘朝晖. 绒毛膜羊膜炎的致病菌及药敏分析 [J]. 中国妇产科临床杂志, 2016, 17(2): 140-143.

18	Pollard K. The fundamental skills: reducing maternal morbidity and mortality [J]. Pract Midwife, 2017, 20(3): 23-25.

19	Albright CM, Has P, Rouse DJ, et al. Internal validation of the sepsis in obstetrics score to identify risk of morbidity from sepsis in pregnancy [J]. Obstet Gynecol, 2017, 130(4): 747-755.

20	Rajkumari N, Mathur P, Sharma S, et al. Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study [J]. J Lab Physicians, 2013, 5(2): 100-108.

21	Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis [J]. Lancet Infect Dis, 2013, 13(5): 426-635.

22	Shirakawa K, Furusako S, Endo S, et al. New diagnostic marker for Sepsis: soluble CD14 subtype [J]. J Crit Care, 2004, 8(Suppl 1): P19l.

23	Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome [J]. J Infect Chemother, 2011, 17(6): 764-769.

24	Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department [J]. Crit Care, 2013, 17(5): R244.

25	Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome [J]. J Infect Chemother, 2011, 17(6): 764-769.

26	Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST) [J]. Clin Chim Acta, 2011, 412(23-24): 2157-2161.

27	Shallcross LJ, Mentzer A, Rahman S, et al. Cohort study protocol: Bioresource in Adult Infectious Diseases (BioAID) [J]. Wellcome Open Res, 2018, 3: 97.

28	Fleuren LM, Klausch TLT, Zwager CL, et al. Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy [J]. Intensive Care Med, 2020, 46(3): 383-400.

29	Neonatal Sepsis Initiative Working Group. Electronic address: bonetm@who.int.The Global Maternal and Neonatal Sepsis Initiative: a call for collaboration and action by 2030 [J]. Lancet Glob Health, 2017, 5: e390-391.

Options

文章导航

模态框（Modal）标题

摘要

本文引用格式

Abstract

参考文献